A study comparing two versions of a medicine in healthy adults
Part of Heart & circulation clinical trials.
This trial tests a new version of a medicine (AD-228B) against the original (AD-2284) to see how they work in the body and if they are safe. Healthy volunteers are needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult aged 19 or older.
- You must weigh at least 50 kg if male, or 45 kg if female.
- Your body mass index (BMI) must be between 18 and 30.
- You cannot have taken part in another drug study in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will compare two versions of a drug (called AD-117 and AD-117A) to see how your body processes them and whether they are safe. You would receive one version and then the other, to compare their effects.
This trial compares two versions of a medicine (AD-116A and AD-1161) to see if they work the same in the body when taken after eating. It is for healthy adult men to help ensure the new version is as good as the original.
This trial tests if two different versions of the study drug AD-116A work the same way in the body. It only includes healthy adult men, so it's not a treatment for a specific disease but helps confirm the drug's safety and absorption.
This study tests how two experimental medications (AD-236A and AD-236B) interact with each other in the body and checks that they are safe for healthy adults. It helps determine how these drugs should be dosed for future treatments.
This trial tests two forms of a new medicine to see how safe they are and how the body handles them. It is for healthy adults aged 19 to 64, and participation helps gather important early information before the drug is studied in patients.
This trial tests how three study drugs interact with each other in healthy adults. It may help find safe doses for future treatments.
Hear when a new Primary Hypercholesterolaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.